(Q39318528)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22770475%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Study of chemoresistant CD133+ cancer stem cells from human glioblastoma cell line U138MG using multiple assays (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22770475%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

main subject

cell line

0 references

neoplastic stem cells

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22770475%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Sudha Warrier

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22770475%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Prathyusha Pavanram

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22770475%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Milan Arvind

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22770475%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

1 reference

1 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22770475%20AND%20SRC:MED&resulttype=core&format=json

Cell Biology International

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22770475%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22770475%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22770475%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

1137-1143

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22770475%20AND%20SRC:MED&resulttype=core&format=json

Prospective identification of tumorigenic breast cancer cells

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

Nonsteroidal anti-inflammatory drugs inhibit the growth of C6 and U138-MG glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

Prostate cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

Breast cancer stem cells revealed

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

Doxorubicin-mediated apoptosis in glioma cells requires NFAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

Suspension culture combined with anticancer regimens for screening breast cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

Secreted PCSK9 promotes LDL receptor degradation independently of proteolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

Isolation and characterization of cancer stem like cells in human glioblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

ABC multidrug transporters: structure, function and role in chemoresistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

Docosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

Chemosensitivity of glioma cells in vitro: a meta analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20110539

21 January 2018

Identifiers

DOI

10.1042/CBI20110539

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22770475%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference